Literature DB >> 11342654

Reactive nitrogen species inhibit alveolar epithelial fluid transport after hemorrhagic shock in rats.

J F Pittet1, L N Lu, D G Morris, K Modelska, W J Welch, H V Carey, J Roux, M A Matthay.   

Abstract

Our recent experimental work demonstrated that a neutrophil-dependent inflammatory response in the lung prevented the normal up-regulation of alveolar fluid clearance by catecholamines following hemorrhagic shock. In this study, we tested the hypothesis that the release of NO within the airspaces of the lung was responsible for the shock-mediated failure of the alveolar epithelium to respond to catecholamines in rats. Hemorrhagic shock was associated with an inducible NO synthase (iNOS)-dependent increase in the lung production of NO and a failure of the alveolar epithelium to up-regulate vectorial fluid transport in response to beta-adrenergic agonists. Inhibition of iNOS restored the normal catecholamine-mediated up-regulation of alveolar liquid clearance. Airspace instillation of dibutyryl cAMP, a stable analog of cAMP, restored the normal fluid transport capacity of the alveolar epithelium after prolonged hemorrhagic shock, whereas direct stimulation of adenyl cyclase by forskolin had no effect. Pretreatment with pyrrolidine dithiocarbamate or sulfasalazine attenuated the iNOS-dependent production of NO in the lung and restored the normal up-regulation of alveolar fluid clearance by catecholamines after prolonged hemorrhagic shock. Based on in vitro studies with an alveolar epithelial cell line, A549 cells, the effect of sulfasalazine appeared to be mediated in part by inhibition of NF-kappaB activation, and the protective effect was mediated by the inhibition of IkappaBalpha protein degradation. In summary, these results provide the first in vivo evidence that NO, released within the airspaces of the lung probably secondary to the NF-kappaB-dependent activation of iNOS, is a major proximal inflammatory mediator that limits the rate of alveolar epithelial transport after prolonged hemorrhagic shock by directly impairing the function of membrane proteins involved in the beta-adrenergic receptor-cAMP signaling pathway in alveolar epithelium.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11342654     DOI: 10.4049/jimmunol.166.10.6301

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  23 in total

1.  Clostridium sordellii lethal toxin kills mice by inducing a major increase in lung vascular permeability.

Authors:  Blandine Geny; Huot Khun; Catherine Fitting; Leticia Zarantonelli; Christelle Mazuet; Nadège Cayet; Marek Szatanik; Marie-Christine Prevost; Jean-Marc Cavaillon; Michel Huerre; Michel R Popoff
Journal:  Am J Pathol       Date:  2007-03       Impact factor: 4.307

Review 2.  Alveolar epithelial beta2-adrenergic receptors.

Authors:  Gökhan M Mutlu; Phillip Factor
Journal:  Am J Respir Cell Mol Biol       Date:  2007-08-20       Impact factor: 6.914

3.  Allogeneic human mesenchymal stem cells for treatment of E. coli endotoxin-induced acute lung injury in the ex vivo perfused human lung.

Authors:  Jae W Lee; Xiaohui Fang; Naveen Gupta; Vladimir Serikov; Michael A Matthay
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-31       Impact factor: 11.205

4.  Frontline Science: D1 dopaminergic receptor signaling activates the AMPK-bioenergetic pathway in macrophages and alveolar epithelial cells and reduces endotoxin-induced ALI.

Authors:  Nathaniel B Bone; Zhongyu Liu; Jean-Francois Pittet; Jaroslaw W Zmijewski
Journal:  J Leukoc Biol       Date:  2016-10-12       Impact factor: 4.962

5.  Activation of the stress protein response inhibits the STAT1 signalling pathway and iNOS function in alveolar macrophages: role of Hsp90 and Hsp70.

Authors:  Marybeth Howard; Jérémie Roux; Hyon Lee; Byron Miyazawa; Jae-Woo Lee; Brandi Gartland; Amanda J Howard; Michael A Matthay; Michel Carles; Jean-François Pittet
Journal:  Thorax       Date:  2010-04       Impact factor: 9.139

Review 6.  Cytokine-Ion Channel Interactions in Pulmonary Inflammation.

Authors:  Jürg Hamacher; Yalda Hadizamani; Michèle Borgmann; Markus Mohaupt; Daniela Narcissa Männel; Ueli Moehrlen; Rudolf Lucas; Uz Stammberger
Journal:  Front Immunol       Date:  2018-01-04       Impact factor: 7.561

7.  Transforming growth factor beta1 inhibits cystic fibrosis transmembrane conductance regulator-dependent cAMP-stimulated alveolar epithelial fluid transport via a phosphatidylinositol 3-kinase-dependent mechanism.

Authors:  Jérémie Roux; Michel Carles; Hidefumi Koh; Arnaud Goolaerts; Michael T Ganter; Brian B Chesebro; Marybeth Howard; Benjamin T Houseman; Walter Finkbeiner; Kevan M Shokat; Agnès C Paquet; Michael A Matthay; Jean-François Pittet
Journal:  J Biol Chem       Date:  2009-12-08       Impact factor: 5.157

8.  IL-8 inhibits cAMP-stimulated alveolar epithelial fluid transport via a GRK2/PI3K-dependent mechanism.

Authors:  Jérémie Roux; Carmel M McNicholas; Michel Carles; Arnaud Goolaerts; Benjamin T Houseman; Dale A Dickinson; Karen E Iles; Lorraine B Ware; Michael A Matthay; Jean-François Pittet
Journal:  FASEB J       Date:  2012-12-06       Impact factor: 5.191

9.  The lectin-like domain of tumor necrosis factor improves lung function after rat lung transplantation--potential role for a reduction in reactive oxygen species generation.

Authors:  Jürg Hamacher; Uz Stammberger; Jeremie Roux; Sanjiv Kumar; Guang Yang; Chenling Xiong; Ralph A Schmid; Richard M Fakin; Trinad Chakraborty; Hamid M D Hossain; Jean-François Pittet; Albrecht Wendel; Stephen M Black; Rudolf Lucas
Journal:  Crit Care Med       Date:  2010-03       Impact factor: 7.598

10.  Nitric oxide production contributes to Bacillus anthracis edema toxin-associated arterial hypotension and lethality: ex vivo and in vivo studies in the rat.

Authors:  Yan Li; Xizhong Cui; Wanying Xu; Lernik Ohanjanian; Hanish Sampath-Kumar; Dante Suffredini; Mahtab Moayeri; Stephen Leppla; Yvonne Fitz; Peter Q Eichacker
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-07-22       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.